Truist Securities Maintains Buy on Addus HomeCare, Raises Price Target to $148
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Truist Securities analyst Clarke Murphy maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $135 to $148.
Truist Securities analyst Clarke Murphy maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $135 to $148.